Cellular Biomedicine Group Inc (CBMG.OQ)
22 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2016||Chairman of the Board|
|50||2016||Chief Executive Officer, Interim Chief Financial Officer, Secretary|
|2015||Chief Scientific Officer|
|2018||Head of Early Diagnosis & Intervention|
|2015||Chief Operation Officer|
- BRIEF-Cellular Biomedicine Group Qtrly Loss Per Share $0.51
- BRIEF-Cellular Biomedicine Announces Positive Clinical Data Of Knee Osteoarthritis China Phase I Trial
- BRIEF-Cellular Biomedicine Group Reports Full-Year 2017 Financial Results And Recent Operational Progress
- BRIEF-Cellular Biomedicine Files For Resale Of Up To 2.9 Mln Shares By Selling Stockholders
- BRIEF-Cellular Biomedicine Group Announces $30.6 Mln Investment From Sailing Capital Overseas Investment